Related Experiment Video
Updated: Aug 23, 2026

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
The microbial content of non-sterile pharmaceuticals distributed in Norway
1Faculty of Health Sciences, Oslo University College, 0167 Oslo, Norway. colin.charnock@hf.hio.no
Abstract:
Seventy-seven registered trademark pharmaceuticals and allied products, not required by the relevant monographs to comply with the test for sterility, were investigated for their microbial content. All the products examined complied with current regulations with respect to the numbers and types of microbes isolated, indicating the effectiveness of existing production practices in meeting existing standards. Gram-positive endospore-forming rods accounted for the majority of the bacteria isolated. Gram-negative rods were present for the most part in incidental numbers. However, some of these were of species that have been previously indicated as opportunistic pathogens and which should be considered as objectionable in pharmaceuticals. A number of the isolates showed antibiotic resistances unusual for the species in question.
Insights
Microbial analysis of 77 non-sterile pharmaceuticals found compliance with regulations. However, some opportunistic pathogens and unusual antibiotic resistances were detected, warranting further pharmaceutical quality assessment.
Area of Science:
- Microbiology
- Pharmaceutical Science
- Quality Control
Background:
- Pharmaceutical products not requiring sterility testing are subject to microbial limits.
- Assessing microbial content is crucial for ensuring product safety and efficacy.
Purpose of the Study:
- To investigate the microbial content of registered trademark pharmaceuticals not mandated for sterility testing.
- To evaluate compliance with existing regulatory standards for microbial contamination.
Main Methods:
- Seventy-seven pharmaceutical products were sampled.
- Microbial content analysis was performed to identify and quantify microorganisms.
- Isolates were characterized, including antibiotic resistance profiling.
Main Results:
- All 77 products met current regulatory standards for microbial numbers and types.
- Gram-positive endospore-forming rods were the predominant bacteria.
- Incidental Gram-negative rods included opportunistic pathogens, and some isolates exhibited unusual antibiotic resistance.
Conclusions:
- Current manufacturing practices effectively meet existing microbial standards for these pharmaceuticals.
- The presence of opportunistic pathogens and unusual antibiotic resistance highlights potential risks.
- Further consideration of objectionable microorganisms and resistance patterns in non-sterile pharmaceuticals is recommended.
Related Concept Videos
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Microorganisms in Medicine and Therapeutics
Clinically Relevant Drug Product Specifications: Methods of Establishment
Physical Methods for Controlling Microbial Growth: Radiation and Filtration
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Methods for Controlling Microbial Growth
